Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

‘Slow science’ lebih cocok untuk riset bidang sosial humaniora di Indonesia

● ‘Slow science’ perlu diterapkan untuk melawan tren “menyampah” (‘junkification’) dalam riset dan publikasi ilmiah.● Riset sosial humaniora membutuhkan...

Blunder Dewan Perdamaian cerminan diplomasi nirkaidah ala Prabowo

Presiden Prabowo Subianto dan sejumlah kepala negara lainnya duduk bersama usai menandatangani Board of Peace (BoP) Charter yang diinisiasi oleh Presiden Amerika Serikat Donald Trump di Davos, Swiss, ...

Bahaya normalisasi doksing: Warganet bisa kebablasan jadi ‘hakim’ moral

(Kenary820/Shutterstock)● Warganet kerap melakukan ‘doxing’ dan merasa berhak menghukum orang yang menurut mereka bersalah.● Doksing merupakan pelanggaran privasi dan termasuk ...